228. Bronchiolitis obliterans Clinical trials / Disease details
Clinical trials : 96 / Drugs : 125 - (DrugBank : 34) / Drug target genes : 33 - Drug target pathways : 155
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02316392 (ClinicalTrials.gov) | December 2014 | 10/12/2014 | Imaging and Understanding BOS in Lung Transplantation | Imaging and Understanding BOS in Lung Transplantation | Bronchiolitis Obliterans Syndrome | Drug: Hyperpolarized Helium-3 MRI | Children's Hospital Medical Center, Cincinnati | NULL | Completed | 1 Year | 25 Years | All | 6 | N/A | United States |